ArticleMolecular therapy. Oncology2024

Rejection resistant CD30.CAR-modified Epstein-Barr virus-specific T cells as an off-the-shelf platform for CD30

David H Quach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.